Litcius/Paper detail

Dupilumab Induces Long-Term On-Treatment Clinical Remission in Patients With Type 2 Asthma

Ian Pavord, Klaus F. Rabe, Elliot Israel, Stanley J. Szefler, Guy Brusselle, Nami Pandit‐Abid, Arman Altincatal, Zhen Chen, Nikhil Amin, Asif Khan, David J. Lederer, Yi Zhang, Paul J. Rowe, Yamo Deniz, Amr Radwan, Juby A. Jacob‐Nara, William W. Busse

2024The Journal of Allergy and Clinical Immunology In Practice37 citationsDOIOpen Access PDF

Topics & Concepts

DupilumabMedicineAsthmaTerm (time)MEDLINEPediatricsDermatologyIntensive care medicineImmunologyQuantum mechanicsLawPhysicsPolitical scienceAsthma and respiratory diseasesDelphi Technique in ResearchIL-33, ST2, and ILC Pathways
Dupilumab Induces Long-Term On-Treatment Clinical Remission in Patients With Type 2 Asthma | Litcius